Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of OCX will decline by -0.87% over the next 2 Weeks and hit $3.17 by Thursday, July 24, 2025. In that time frame, OCX's share price is expected to range between $2.84 and $3.50.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 24, 2025 | 2.84 | 3.17 | 3.51 |
| Jul 23, 2025 | 2.83 | 3.16 | 3.50 |
| Jul 22, 2025 | 2.85 | 3.20 | 3.53 |
| Jul 21, 2025 | 2.87 | 3.17 | 3.51 |
| Jul 18, 2025 | 2.87 | 3.19 | 3.54 |
| Jul 17, 2025 | 2.81 | 3.15 | 3.46 |
| Jul 16, 2025 | 2.82 | 3.13 | 3.46 |
| Jul 15, 2025 | 2.85 | 3.17 | 3.51 |
| Jul 14, 2025 | 2.82 | 3.14 | 3.50 |
| Jul 11, 2025 | 2.84 | 3.17 | 3.48 |
OCX shares rose +17.22% in Tuesday, June 17, 2025's trading session, rising from a previous close of $2.73 to move at $3.20. The stock demonstrated notable intraday movement (see OCX's key stats for a full breakdown), fluctuating between $2.82 and $3.20, a +13.48% trading range. While recent weeks have seen some volatility, OCX has managed to secure a +21.21% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 33.4K shares changing hands, 2.95K more than the previous session. This amounted to $106.86K in total market activity.
Will OCX Continue Its Upward Trend?
According to analyst ratings and projections for OCX, OncoCyte Corporation shares are anticipated to increase by +8.90%, potentially reaching $3.51 per share by July 24, 2025. Short-term technical indicators currently suggest a neutral sentiment for OCX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the OCX stock forecast, now is a good time to buy OCX stock because its current trading price is +0.88% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on OCX covering social and institutional perspectives.
OCX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into OCX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.86% to 46.00%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.78%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.40%, maintains a neutral outlook for the long term. Insights into OCX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
OncoCyte Short-Term Forecasts
OCX Forecast For Next 5 Days
Our algorithm anticipates OncoCyte (OCX) stock could hit $3.03 by Jul 18, 2025. This represents a -5.23% rise from today's price, following a +15.94% change over the past five days.
OCX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for OncoCyte Corporation (OCX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.23, which would mean a +0.94% increase from the current price of $3.20. Projections for this period range from a high of $3.73 to a low of $2.81.
OCX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for OncoCyte's price over the next three months point to a rise. OCX stock is expected to peak at $6.99 on May 08, 2026 after potentially dipping to $3.86 on Apr 15, 2026. On average, OCX is likely to trade around $5.44 in the coming 90 days.
OncoCyte Stock Forecast 2025
Based on our predictive models, OncoCyte (OCX) is expected to trade between $3.84 and $7.53 throughout 2026. This would result in an average price of $5.69, potentially offering investors a +77.81% return from current levels.
OncoCyte Corporation Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, OncoCyte Corporation (OCX) is positioned to show a strong performance in July 2025. The price is predicted to move between $5.45 and $7.15, settling at an average of $6.13. This could translate to a +91.56% gain.
August 2025
Based on current market signals, OncoCyte Corporation is projected to trend august 2025. We forecast a trading range from $5.07 to $7.12, with a likely average price of $6.20. Investors could expect a potential return of +93.75%.
September 2025
Our predictive algorithms indicate OncoCyte Corporation stock may see a shift in September 2025. The expected range spans $4.66–$6.40, with an average target of $5.43. This represents a positive outlook and a possible gain of +69.69%.
October 2025
Analyzing established trends, OncoCyte Corporation looks set to move in October 2025. Projections place the stock between $4.92 and $6.57, averaging around $5.71. This suggests a +78.44% gain from current levels.
November 2025
Market indicators suggest OncoCyte Corporation could experience notable changes during November 2025. Prices could fluctuate within $2.78 to $5.09, with a midpoint forecast of $4.00. The stock might deliver a +25.00% gain.
December 2025
Forecasting for December 2025, models estimate that OncoCyte Corporation may undergo key fluctuations. If trends hold, the stock might trade between $3.90 and $5.70, averaging $4.85. This signals a positive trajectory with potential returns around +51.56%.
January 2026
According to our latest forecast models, OncoCyte Corporation (OCX) is positioned to show a strong performance in January 2026. The price is predicted to move between $4.23 and $6.33, settling at an average of $5.52. This could translate to a +72.50% gain.
February 2026
Based on current market signals, OncoCyte Corporation is projected to trend february 2026. We forecast a trading range from $3.84 to $6.78, with a likely average price of $5.40. Investors could expect a potential return of +68.75%.
March 2026
Our predictive algorithms indicate OncoCyte Corporation stock may see a shift in March 2026. The expected range spans $4.15–$6.12, with an average target of $5.29. This represents a positive outlook and a possible gain of +65.31%.
April 2026
Analyzing established trends, OncoCyte Corporation looks set to move in April 2026. Projections place the stock between $3.86 and $6.28, averaging around $5.17. This suggests a +61.56% gain from current levels.
May 2026
Market indicators suggest OncoCyte Corporation could experience notable changes during May 2026. Prices could fluctuate within $4.71 to $7.53, with a midpoint forecast of $6.54. The stock might deliver a +104.38% gain.
June 2026
Forecasting for June 2026, models estimate that OncoCyte Corporation may undergo key fluctuations. If trends hold, the stock might trade between $4.13 and $7.18, averaging $6.32. This signals a positive trajectory with potential returns around +97.50%.
OCX's history of dividends and stock splits also plays a role in long-term investor confidence.